Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2204]

Pancreatic cancer cells secrete signal that sabotages immune attack on tumours

Pancreatic cancer cells secrete signal that sabotages immune attack on tumours

Cancer mortality continues rapid decline, driven by progress against lung cancer

Cancer mortality continues rapid decline, driven by progress against lung cancer

Complex innovative trials: Authors call for new guideline adoption to get medicines to patients faster

Complex innovative trials: Authors call for new guideline adoption to get medicines to patients faster

FDA approves new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies

FDA approves new treatment option for patients with HER2-positive breast cancer who have progressed on available...

Recent screening rose among people under 50 after release of new colorectal guidelines

Recent screening rose among people under 50 after release of new colorectal guidelines

FDA approves new type of therapy to treat advanced urothelial cancer

FDA approves new type of therapy to treat advanced urothelial cancer

FDA approves enzalutamide for metastatic castration-sensitive prostate cancer

FDA approves enzalutamide for metastatic castration-sensitive prostate cancer

Does evidence support BRCA1/2 and other genetic testing for patients with breast cancer?

Does evidence support BRCA1/2 and other genetic testing for patients with breast cancer?

Standard pathology tests outperform molecular subtyping in bladder cancer

Standard pathology tests outperform molecular subtyping in bladder cancer

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

More from ecancer